Interview 13 May 2019 Putting DNA Repair on the Map Niall Martin is on a mission to put DNA repair on the map. He has already gone pretty far along the way to doing this, as the leader of the team that developed the blockbuster cancer drug Lynparza. He is now seeking to repeat this early success at Artios, where he is CEO. Martin talked […] May 13, 2019 - 8 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
Startup Scout 10 May 2019 This Biotech Destroys Cancer Proteins by Introducing Them to ‘Executioner’ Proteins Nestled in the biotech hub of Cambridge, UK, is Polyprox. Less than a year old, this company is developing a new class of protein-based drugs that could treat cancer by degrading key proteins in the cancer cell. Mission: Develop drugs that destroy proteins in cancer cells by recruiting executioner proteins, called ligases. Polyprox develops protein […] May 10, 2019 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Interview 9 May 2019 A 20-Year Journey to Nail Down an Undruggable Cancer Target The ultimate goal of cancer research is to bring to the market a drug that improves the treatment of patients lacking options. Laura Soucek, CEO of the startup Peptomyc, shares the story of her journey to take a cancer treatment against an until now undruggable target to the clinic. It all started when Soucek was […] May 9, 2019 - 5 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Best in Biotech 8 May 2019 Top 10 Biotechs in Lausanne The Swiss city of Lausanne is perhaps best known as a hub of international sport, but what many outsiders may not realize is that it’s also one of Switzerland’s biggest biotech hubs. Many of the biotechs in the city are connected to the University of Lausanne (UNIL), as well as the renowned Swiss Federal Institute […] May 8, 2019 - 7 minutesmins - By David Cox Share WhatsApp Twitter Linkedin Email
News and Trends 1 May 2019 Next-Generation CAR-T Therapy Shows Promise in Child’s Neuroblastoma Cell Medica’s next-generation CAR-T cell therapy has resulted in ‘extensive tumor regression’ in a child with high-risk neuroblastoma, one of the deadliest types of childhood cancer. Only available to cancer patients for the last couple of years, CAR-T cell therapy has had impressive results in treating patients for whom other available options do […] May 1, 2019 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 30 Apr 2019 Swiss Biotech Raises €11M to Develop Treatments for Liver Fibrosis Founded in March this year, Alentis Therapeutics has bagged a Series A round of €11.1M (CHF 12.5M) to develop antibody drugs treating liver fibrosis, which currently has no approved treatments. Liver fibrosis is the scarring of liver tissue, which can happen as a consequence of aging, chronic hepatitis or conditions such as non-alcoholic steatohepatitis (NASH). […] April 30, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 23 Apr 2019 Combining DNA and RNA Testing Could Improve Precision Medicine for Cancer An international clinical trial has shown that extending cancer testing beyond genetic mutations has potential to improve the personalized treatment of cancer. In recent years, the field of precision medicine has been rapidly growing and is bringing a lot of hope to both patients and physicians, especially in the diagnosis and treatment of […] April 23, 2019 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 11 Apr 2019 Swiss Multi-Cancer Diagnostic Test Approved in Europe A cancer test developed by the Swiss company SOPHiA GENETICS has been approved for diagnosing multiple types of solid tumors by looking at genetic variations in 42 genes. SOPHiA GENETICS works in data-driven medicine, using huge amounts of genomic data to diagnose and personalize treatments to a patient. This new technology is being adopted by […] April 11, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 29 Mar 2019 Liquid Biopsy for Lung Cancer Gets €46M Boost Inivata has raised a €46M (£40M) Series B round that will further advance the commercialization of the company’s blood test for lung cancer as well as the development of new tests. Investors include Woodford patient Capital Trust, IP Group, Cambridge Innovation Capital, Johnson & Johnson Innovation and RT Ventures. Based in both the US and […] March 29, 2019 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 27 Mar 2019 Artificial Intelligence Could Beat Tumors Resistant to Immunotherapy The French company OSE Immunotherapeutics has signed a partnership to use artificial intelligence to develop treatments for tumors that don’t respond to checkpoint inhibitor drugs. In the last five years, checkpoint inhibitor drugs have become a potentially life-saving option for people that don’t respond to traditional cancer treatments. These antibody drugs have shown promise in […] March 27, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 20 Mar 2019 Czech Cell Therapy Increases Survival in Ovarian Cancer by 62% The Czech biotech company Sotio has shown in a phase II trial that its cellular immunotherapy can decrease the risk of a patient dying from ovarian cancer by 62%. The cell therapy was tested in people with the most severe stages of recurrent ovarian cancer, in combination with second-line chemotherapy when cancer returned after […] March 20, 2019 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 27 Feb 2019 UK Biotech Gets Huge Grant to Launch Off-the-Shelf CAR-T Cancer Therapy to Clinic The UK biotech Cell Medica has received a €7.6M ($8.7M) grant from the Cancer Prevention and Research Institute of Texas to advance an off-the-shelf CAR-T cell therapy that can work not only in blood cancer but also in solid tumors. The funding will help the company to develop a special type of CAR-T cell therapy […] February 27, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email